{
  "id": 12174479,
  "title": "Vaxcyte's pneumococcal vaccine succeeds in Phase 3, stock surges",
  "url": "https://urgent.news/2026/10/05/vaxcytes-pneumococcal-vaccine-succeeds-in-phase-3-stock-surges",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-05T15:06:23.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/vaxcytes-pneumococcal-vaccine-succeeds-in-phase-3-stock-surges/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Vaxcyte's shares {$PCVX} jumped 35% Monday morning after the company announced that its experimental pneumococcal vaccine VAX-31 met its key endpoints in a Phase 3 trial with adults, a major step in its quest to ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}